| P50 | author | Andreas Gnirke | Q29397647 |
| | Dirk Schadendorf | Q32649390 |
| | Nir Hacohen | Q42799920 |
| | Rupert Langer | Q56422424 |
| | Alexander Meissner | Q74886189 |
| | Donna Neuberg | Q87319577 |
| | Jedd D. Wolchok | Q88137705 |
| | Levi A Garraway | Q89916155 |
| | F Stephen Hodi | Q90321337 |
| P2093 | author name string | Catherine J Wu | |
| | George F Murphy | |
| | Jeffrey S Weber | |
| | Qian Zhan | |
| | Ying Huang | |
| | Eliezer M Van Allen | |
| | Sachet A Shukla | |
| | Daniel Gusenleitner | |
| | Taha Merghoub | |
| | Bastian Schilling | |
| | Patrick C Lee | |
| | Derin B Keskin | |
| | Alexandra Snyder | |
| | Christine G Lian | |
| | Christina Galonska | |
| | Diana Miao | |
| | Kendell Clement | |
| | Clyde Bango | |
| | Mehrtash Babadi | |
| | Pavan Bachireddy | |
| | Patrick R Potts | |
| | Zachary J Cartun | |
| | Arman Mohammad | |
| P2860 | cites work | Endogenous HMGB1 regulates autophagy | Q24298865 |
| | MAGE-RING Protein Complexes Comprise a Family of E3 Ubiquitin Ligases | Q24300816 |
| | A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma | Q24319940 |
| | The basics of epithelial-mesenchymal transition | Q24652992 |
| | Nivolumab plus ipilimumab in advanced melanoma | Q27852310 |
| | Improved Survival with Ipilimumab in Patients with Metastatic Melanoma | Q27861062 |
| | Structure, chromosomal localization, and expression of 12 genes of the MAGE family | Q28238754 |
| | Metabolic-stress-induced rearrangement of the 14-3-3ζ interactome promotes autophagy via a ULK1- and AMPK-regulated 14-3-3ζ interaction with phosphorylated Atg9 | Q28248842 |
| | Restoring function in exhausted CD8 T cells during chronic viral infection | Q28289222 |
| | RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome | Q29547458 |
| | HTSeq--a Python framework to work with high-throughput sequencing data | Q29614489 |
| | STAR: ultrafast universal RNA-seq aligner | Q29615052 |
| | Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice | Q29615615 |
| | Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors | Q29615665 |
| | Cancer/testis antigens, gametogenesis and cancer | Q29616129 |
| | Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy | Q29619961 |
| | Genetic basis for clinical response to CTLA-4 blockade in melanoma | Q29620594 |
| | Sequential administration of nivolumab and ipilimumab with a planned switch in patients with advanced melanoma (CheckMate 064): an open-label, randomised, phase 2 trial | Q30276649 |
| | Fasting-Mimicking Diet Reduces HO-1 to Promote T Cell-Mediated Tumor Cytotoxicity | Q33554629 |
| | Absolute quantification of somatic DNA alterations in human cancer | Q34271693 |
| | Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy | Q34399765 |
| | Single dose of anti-CTLA-4 enhances CD8+ T-cell memory formation, function, and maintenance | Q34472025 |
| | Genomic Classification of Cutaneous Melanoma | Q34670776 |
| | Tumor-specific shared antigenic peptides recognized by human T cells | Q35005926 |
| | Characterization of the immunophenotypes and antigenomes of colorectal cancers reveals distinct tumor escape mechanisms and novel targets for immunotherapy. | Q35227810 |
| | Integrated NY-ESO-1 antibody and CD8+ T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab | Q35289145 |
| | Melanoma Cell-Intrinsic PD-1 Receptor Functions Promote Tumor Growth | Q36429062 |
| | PANTHER version 10: expanded protein families and functions, and analysis tools. | Q36434795 |
| | The mRNA-edited form of GABRA3 suppresses GABRA3-mediated Akt activation and breast cancer metastasis | Q36582294 |
| | Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma | Q36730827 |
| | Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma | Q37222679 |
| | Prospective assessment of a gene signature potentially predictive of clinical benefit in metastatic melanoma patients following MAGE-A3 immunotherapeutic (PREDICT). | Q37281267 |
| | Genomic correlates of response to CTLA-4 blockade in metastatic melanoma | Q37319470 |
| | Prognostic relevance of autophagy markers LC3B and p62 in esophageal adenocarcinomas | Q37457478 |
| | Autophagy in T-cell development, activation and differentiation | Q38257296 |
| | Loss of IFN-γ Pathway Genes in Tumor Cells as a Mechanism of Resistance to Anti-CTLA-4 Therapy | Q38743794 |
| | Caloric Restriction Mimetics Enhance Anticancer Immunosurveillance | Q38758370 |
| | Androgen receptor antagonists compromise T cell response against prostate cancer leading to early tumor relapse | Q38780080 |
| | Reliable LC3 and p62 autophagy marker detection in formalin fixed paraffin embedded human tissue by immunohistochemistry | Q38856019 |
| | A Comprehensive Guide to the MAGE Family of Ubiquitin Ligases | Q39181769 |
| | Coordinated expression of clustered cancer/testis genes encoded in a large inverted repeat DNA structure | Q39994276 |
| | Efficacy of the MAGE-A3 cancer immunotherapeutic as adjuvant therapy in patients with resected MAGE-A3-positive non-small-cell lung cancer (MAGRIT): a randomised, double-blind, placebo-controlled, phase 3 trial | Q40692551 |
| | Recurrent SERPINB3 and SERPINB4 mutations in patients who respond to anti-CTLA4 immunotherapy | Q41358442 |
| | Degradation of AMPK by a cancer-specific ubiquitin ligase | Q42276010 |
| | MAGE-A3 is a frequent tumor antigen of metastasized melanoma | Q45167053 |
| | Tumor-infiltrating lymphocyte grade is an independent predictor of sentinel lymph node status and survival in patients with cutaneous melanoma. | Q50935715 |
| | Autophagy mediates transporter associated with antigen processing-independent presentation of viral epitopes through MHC class I pathway | Q64379119 |
| | Tumor antigen expression in melanoma varies according to antigen and stage | Q82506715 |
| | SnapShot: cancer vaccines | Q87666307 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 624-633.e8 | |
| P577 | publication date | 2018-04-06 | |
| P1433 | published in | Cell | Q655814 |
| P1476 | title | Cancer-Germline Antigen Expression Discriminates Clinical Outcome to CTLA-4 Blockade. | |
| P478 | volume | 173 | |